PRL and breast carcinoma: For example, a positive family history of breast cancer and genes such as BRCA1/2, important risk factors for breast cancer, may motivate the selection of a prolactin-sparing antipsychotic, although there was limited evidence of this potential association available during the study period, reducing the likelihood that it would have had an important effect on the results.